These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1094 related articles for article (PubMed ID: 19245155)

  • 1. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
    Müller FM; Staudigel A; Salvenmoser S; Tredup A; Miltenberger R; Herrmann JV
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3014-6. PubMed ID: 17548494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.
    Kwamin F; Nartey NO; Codjoe FS; Newman MJ
    J Infect Dev Ctries; 2013 Jan; 7(1):41-5. PubMed ID: 23324819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M; Tennagen I; Engelmann E
    Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
    Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
    Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
    Hung CC; Yang YL; Lauderdale TL; McDonald LC; Hsiao CF; Cheng HH; Ho YA; Lo HJ
    J Clin Microbiol; 2005 Apr; 43(4):1600-3. PubMed ID: 15814972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
    Migliorati CA; Birman EG; Cury AE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M; Müller FM
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.